Restasis and Rinvoq drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Restasis (cyclosporine) and Rinvoq (upadacitinib). Common drug interactions include surgery among females and adverse drug reaction among males.
The phase IV clinical study analyzes what interactions people have when they take Restasis and Rinvoq. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.
What is Rinvoq?
Rinvoq has active ingredients of upadacitinib. eHealthMe is studying from 47,375 Rinvoq users. Check the latest studies of Rinvoq.
60 people who take Restasis and Rinvoq together, and have interactions are studied.

What are the common drug interactions of Restasis and Rinvoq, by gender? *:
female:
- Surgery
- Nausea (feeling of having an urge to vomit)
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Headache (pain in head)
- Vomiting
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pain in extremity
- Gait disturbance
- Neoplasm malignant (cancer tumour)
- Asthenia (weakness)
male:
- Adverse drug reaction
- Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
- Drug hypersensitivity
- Eye pain
- Genital pain (pain in genital)
- Hepatic steatosis (fatty liver disease)
- Ocular hyperaemia (an abnormally large amount of blood in eye)
- Pain
- Pyrexia (fever)
What are the common drug interactions of Restasis and Rinvoq, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Surgery
- Pain
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
50-59:
- Sinusitis (inflammation of sinus)
- Headache (pain in head)
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Skin cancer
- Acne (skin problems that cause pimples)
- Allergy to arthropod sting
- Arthropod sting (arthropod bite)
- Cardiac disorder
- Contusion (a type of hematoma of tissue in which capillaries)
60+:
- Pain
- Gait disturbance
- Pneumonia
- Pulmonary mass
- Renal cancer (cancer of kidney)
- Thyroid mass
- Ageusia (loss of taste functions of the tongue)
- Anosmia (partial or complete loss of the sense of smell)
- Headache (pain in head)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 43 people, 71.67%
- High Blood Pressure: 7 people, 11.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.00%
- High Blood Cholesterol: 5 people, 8.33%
- Osteoporosis (bones weak and more likely to break): 4 people, 6.67%
- Muscle Spasms (muscle contraction): 4 people, 6.67%
- Hypersensitivity: 4 people, 6.67%
- Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 6.67%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 5.00%
- Pain: 3 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Restasis and Rinvoq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Restasis and Rinvoq:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rinvoq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Restasis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rinvoq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on cyclosporine and upadacitinib (the active ingredients of Restasis and Rinvoq, respectively), and Restasis and Rinvoq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Levothroid cause Irritable Bowel Syndrome? - 14 seconds ago
- Could Methylprednisolone cause Wheezing? - 21 seconds ago
- Could Tavist cause High Blood Cholesterol? - 28 seconds ago
- Could Insulin cause Blood Bicarbonate Decreased? - 37 seconds ago
- Drug interactions of Boswellia Serrata and Magnesium - 40 seconds ago
- Drug interactions of Bosulif and Lisinopril - 42 seconds ago
- Chronic Thyroiditis and Joint Stiffness - 52 seconds ago
- Could Topamax cause Blood Thyroid Stimulating Hormone Increased? - 56 seconds ago
- Could Turalio cause Urticaria? - 57 seconds ago
- Could Azor cause Peptic Ulcer Aggravated? - a minute ago